Skip to content

Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure

Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02046707
Enrollment
71
Registered
2014-01-28
Start date
2014-08-29
Completion date
Unknown
Last updated
2019-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure, Reconditioning to Effort

Brief summary

This is a single-centre open randomized parallel-group study. Patients will be selected at random to be included in group 1: eccentric rehabilitation or group 2: conventional rehabilitation. In addition, a group of healthy volunteers aged between 20 and 85 years will also be recruited. This group will make it possible to evaluate, during the two exercise sessions, mechanisms of adaptation linked to eccentric exercise vs concentric exercise.

Interventions

OTHERPeriod of cardiac rehabilitation
OTHERfinal evaluation
OTHERConcentric and eccentric exercise sessions

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 85 Years

Inclusion criteria

Patients : * Patients who have provided written informed consent * Patients with national health insurance cover * Men or women aged between 45 and 85 years with stabilized chronic heart failure (ischemic or dilated cardiopathy) for at least one month, New York Heart Association stage\> 2. * Echocardiographic left ventricular ejection fraction (Simpson method) \< 45% OR N-terminal-ProBNP \> 3 x upper limit of normal\* (\*= 125pg/ml for the CHU laboratory). * First period of rehabilitation for chronic heart failure. Healthy volunteers: * Subjects who have provided written informed consent * Subjects with national health insurance cover * Men or women aged between 18 and 85 years.

Exclusion criteria

Patients: * persons without national health insurance cover * Severe obstructive cardiopathy, * severe aortic valve stenosis, * severe progressive heart rhythm or conduction disorders not corrected with a pacemaker, discovered at the initial effort test * intra-cavitary thrombus, * severe pulmonary artery hypertension (systolic pulmonary arterial hypertension \>70mmHg), * recent history of venous trombo-embolism (last 3 months), * impaired executive function making it impossible to understand and follow reconditioning programme (Mini Mental Test \< 24), * heart transplant, * associated medical disorders that could predominately impair functional capacity compared with the chronic heart failure (examples: respiratory insufficiency, non-stabilized metabolic disorders such as progressive kidney failure, severe asthenia related to a severe non-stabilized disorder such as neoplasia, systemic disease…). associated chronic motor deficit of a neurological origin (example: sequelae of a cerebrovascular accident), an osteo-articular origin (example: impairment due to Rheumatoid arthritis), of a peripheral vascular disease (example: peripheral artery disease, venous disease, lymphedema) will not be included in the

Design outcomes

Primary

MeasureTime frame
Evolution of performance in the 6-minute walk test between the initial assessment and the final assessment of a reconditioning programme12 weeks

Secondary

MeasureTime frame
Evolution of functional and physiological capacities and tolerance criteria12 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026